I. van der Horst

PB1160 Detection of Drug-Induced Platelet Inhibition with Sonic Estimation of Elasticity via Resonance Using the QuantraTM: An Observational invitro Study with Healthy Volunteers

Jan Royce Linton Krumeich, R. Chin Kwie Joe, Marc P. Buise, I. van der Horst et autres

Clinical presentation, disease course and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease – a cohort study across eighteen countries

Marijke Linschoten, Alicia Uijl, Astrid Schut, C E M Jakob et autres

Abstract Aims Patients with cardiac disease are considered high risk for poor outcomes following hospitalization with COVID-19. The primary aim of this study was to evaluate heterogeneity in associations between various heart disease subtypes and in-hospital mortality. Method and results We used …

nl, de, gb, ch, sa, be, ru (code pays fourni par la source)

AB1043 Etanercept Retention Rates in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis or Psoriatic Arthritis

Christel van Dongen, Eva L. Kneepkens, Erik H Vogelzang, Merel J l'Ami et autres

nl, us (code pays fourni par la source)

Phase I trial of SU14813 in patients with advanced solid malignancies

Walter Fiedler, Giuseppe Giaccone, Peter Lasch, I. van der Horst et autres

de, nl, it, us (code pays fourni par la source)

Phase I trial of SU014813 in patients (pts) with advanced solid malignancies

Walter Fiedler, Giuseppe Giaccone, Peter Lasch, I. van der Horst et autres

3521 Background: SU014813 is an oral multi-targeted small molecule RTK inhibitor of VEGFRs, PDGFRs, sKIT & FLT-3 at nM concentrations. This study was designed to determine the safety, PK, PD, & preliminary efficacy of SU014813. Methods: Cohorts of pts with (w/) relapsed …

de, gb (code pays fourni par la source)

Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections: a phase I and pharmacokinetic study in patients with advanced cancer

Annemarie H.G. Hansma, H J Broxterman, I. van der Horst, Y. Yuana et autres

nl (code pays fourni par la source)

ISSAS: International Start TNF-blocker Study in Ankylosing Spondylitis

Thao Pham, Robert L. Landewé, Maxime Dougados, R Burgos-Vargas et autres

Hydrocortisone induces hypernatriemia

No Value Ptackova, Jjm Ligtenberg, I. van der Horst, Mwn Nijsten

Decreased renal glucose-threshold in ICU patients

MA Schoorl, Mathijs Vogelzang, I. van der Horst, Hugo de Wit et autres

Mean hyperglycemia as a measure of glucose regulation

Mathijs Vogelzang, I. van der Horst, Mwn Nijsten

Long term clinical outcome of ST segment elevation myocardial infarction patients with and without diabetes mellitus in the Zwolle Trial.

No Value Timmer, I. van der Horst, Jps Henriques, Krupa Sara Thomas et autres

Glucose-insulin-potassium infusion in primary angioplasty for acute myocardial infarction: clinical results in all patients and patients with diabetes mellitus.

I. van der Horst, H.J.G. Bilo, Jorik R. Timmer, A Van'T Hof et autres